Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker.
about
Screening and identification of serum proteomic biomarkers for gastric adenocarcinoma.Identification of proteins associated with lymph node metastasis of gastric cancer.Progress in the development of protein biomarkers of oesophageal and gastric cancers.14-3-3β Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells by Modulating Expression of MMP2 and MMP9 through PI3K/Akt/NF-κB PathwayWhat gastric cancer proteomic studies show about gastric carcinogenesis?Revealing the anti-tumor effect of artificial miRNA p-27-5p on human breast carcinoma cell line T-47D.Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray.Discovery of SLC3A2 cell membrane protein as a potential gastric cancer biomarker: implications in molecular imaging.Combination of OipA, BabA, and SabA as candidate biomarkers for predicting Helicobacter pylori-related gastric cancer.Overexpression of ADP-ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance.YWHAE silencing induces cell proliferation, invasion and migration through the up-regulation of CDC25B and MYC in gastric cancer cells: new insights about YWHAE role in the tumor development and metastasis process.Role of 14-3-3-beta in the migration and invasion in human malignant glioma cell line U87MG.Proteomics approach to identify biomarkers for upper gastrointestinal cancer.Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics.Proteome profiling of spinal cord and dorsal root ganglia in rats with trinitrobenzene sulfonic acid-induced colitis.Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells.Clinical significance of serum 14-3-3 beta in patients with hepatocellular carcinoma.Pretreatment 14-3-3 epsilon level is predictive for advanced extranodal NK/T cell lymphoma therapeutic response to asparaginase-based chemotherapy.
P2860
Q34411956-1A8114E9-94F0-46BA-B70D-BC69AAD19947Q35168606-ACFB87BF-5B00-40C9-B7EE-AEC58CA4D7B6Q35845797-D1CB2AF7-1113-4260-AAAB-606B7E9E6FB9Q35885159-736F54CB-7673-44B6-AAE7-6E144D7EF58AQ36002404-07B850C6-C59A-44CD-AC0E-FB67B961ED53Q36057353-D5FEEB07-90C8-4E18-97BC-F9C8E0076157Q36539497-18F2AF65-9BC3-4976-AC82-7C8D25C16AF0Q37111705-A7BD0C94-4DEC-4305-BE56-1A8A12AA843CQ37397372-367F042E-2F54-4508-AFA7-DEE4FD351530Q37682026-D21D167B-FABC-423A-8A64-DDDC89915C86Q37709154-566B6877-B573-452F-A51A-B843928434B2Q38459041-0232A4CB-D758-484C-BBF3-CF879B5D311BQ38975703-A1CA64B2-7DFD-4C80-88B4-1B294F70FB90Q38981782-87705CFE-6E90-4E5C-885D-26849EBD30FEQ41928668-1F89550F-D02C-41B2-98FC-59FF8A885F32Q46797867-5BDF135D-C336-42A7-ACD0-FE9B3B22C592Q47860772-3B4E849D-BA99-47D2-8154-A5C14566F1DAQ51367284-2C678BD0-0987-471F-B8A9-94D1D60148C6
P2860
Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification of 14-3-3β in h ...... stic and prognostic biomarker.
@ast
Identification of 14-3-3β in h ...... stic and prognostic biomarker.
@en
type
label
Identification of 14-3-3β in h ...... stic and prognostic biomarker.
@ast
Identification of 14-3-3β in h ...... stic and prognostic biomarker.
@en
prefLabel
Identification of 14-3-3β in h ...... stic and prognostic biomarker.
@ast
Identification of 14-3-3β in h ...... stic and prognostic biomarker.
@en
P2093
P2860
P50
P356
P1433
P1476
Identification of 14-3-3β in h ...... stic and prognostic biomarker.
@en
P2093
Chen-Ching Lin
Chien-Wei Tseng
Kai-Neng Chuang
King-Jen Chang
P2860
P304
P356
10.1002/PMIC.201000449
P577
2011-05-20T00:00:00Z